-
1
-
-
0025218031
-
The prostate: An increasing medical problem
-
Ballentine CH, Coffey DS: The prostate: An increasing medical problem. Prostate 1990;16:39-48.
-
(1990)
Prostate
, vol.16
, pp. 39-48
-
-
Ballentine, C.H.1
Coffey, D.S.2
-
2
-
-
0023201899
-
Peptide-hormone- And serotonin-immunoreactive tumor cells in carcinoma of the prostate
-
Abrahamsson PA, Wadstrom LB, Alumets J, Falkmer S, Grimelius L: Peptide-hormone- and serotonin-immunoreactive tumor cells in carcinoma of the prostate. Pathol Res Pract 1987;182:298-307.
-
(1987)
Pathol Res Pract
, vol.182
, pp. 298-307
-
-
Abrahamsson, P.A.1
Wadstrom, L.B.2
Alumets, J.3
Falkmer, S.4
Grimelius, L.5
-
3
-
-
0023553021
-
Neuroendocrine differentiation in prostatic carcinoma
-
di Sant'Agnese PA, de Mesy Jensen KL: Neuroendocrine differentiation in prostatic carcinoma. Hum Pathol 1987;18:849-856.
-
(1987)
Hum Pathol
, vol.18
, pp. 849-856
-
-
Di Sant'Agnese, P.A.1
De Mesy Jensen, K.L.2
-
4
-
-
0027319765
-
Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma
-
Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE: Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993;71:3952-3965.
-
(1993)
Cancer
, vol.71
, pp. 3952-3965
-
-
Aprikian, A.G.1
Cordon-Cardo, C.2
Fair, W.R.3
Reuter, V.E.4
-
5
-
-
0028214994
-
Neuroendocrine differentiation in metastatic prostatic adenocarcinoma
-
Aprikian AG, Cordon-Cardo C, Fair WR, Zhang ZF, Bazinet M, Hamdy S, Reuter VE: Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol 1994;151:914-919.
-
(1994)
J Urol
, vol.151
, pp. 914-919
-
-
Aprikian, A.G.1
Cordon-Cardo, C.2
Fair, W.R.3
Zhang, Z.F.4
Bazinet, M.5
Hamdy, S.6
Reuter, V.E.7
-
6
-
-
0029680203
-
Neuroendocrine differentiation in prostatic malignancy
-
di Sant'Agnese PA, Cockett AT: Neuroendocrine differentiation in prostatic malignancy. Cancer 1996;78:357-361.
-
(1996)
Cancer
, vol.78
, pp. 357-361
-
-
Di Sant'Agnese, P.A.1
Cockett, A.T.2
-
7
-
-
0024440505
-
The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker"
-
Abrahamsson PA, Falkmer S, Falt K, Grimelius L: The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker." Pathol Res Pract 1989;185:373-380.
-
(1989)
Pathol Res Pract
, vol.185
, pp. 373-380
-
-
Abrahamsson, P.A.1
Falkmer, S.2
Falt, K.3
Grimelius, L.4
-
8
-
-
0026355799
-
Elevated plasma chromogranin-A concentrations in prostatic carcinoma
-
Kadmon D, Thompson TC, Lynch GR, Scardino PT: Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J Urol 1991;146:358-361.
-
(1991)
J Urol
, vol.146
, pp. 358-361
-
-
Kadmon, D.1
Thompson, T.C.2
Lynch, G.R.3
Scardino, P.T.4
-
9
-
-
0026071763
-
Neuropeptide growth factors and cancer
-
Woll PJ: Neuropeptide growth factors and cancer. Br J Cancer 1991;63:469-475.
-
(1991)
Br J Cancer
, vol.63
, pp. 469-475
-
-
Woll, P.J.1
-
10
-
-
0023471219
-
A role for neuropeptides in the control of cell proliferation
-
Zachary I, Woll PJ, Rozengurt E: A role for neuropeptides in the control of cell proliferation. Dev Biol 1987;124:295-308.
-
(1987)
Dev Biol
, vol.124
, pp. 295-308
-
-
Zachary, I.1
Woll, P.J.2
Rozengurt, E.3
-
11
-
-
0024554552
-
Bombesin stimulates growth of human prostatic cancer cells in vitro
-
Bologna M, Festuccia C, Muzi P, Biordi L, Ciomei M: Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 1989;63:1714-1720.
-
(1989)
Cancer
, vol.63
, pp. 1714-1720
-
-
Bologna, M.1
Festuccia, C.2
Muzi, P.3
Biordi, L.4
Ciomei, M.5
-
12
-
-
0030014619
-
Bombesin specially induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells
-
Aprikian AG, Han K, Chevalier S, Bazinet M, Viallet J: Bombesin specially induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells. J Mol Endocrinol 1996;16:297-306.
-
(1996)
J Mol Endocrinol
, vol.16
, pp. 297-306
-
-
Aprikian, A.G.1
Han, K.2
Chevalier, S.3
Bazinet, M.4
Viallet, J.5
-
13
-
-
0027189659
-
Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells
-
Hoosein NM, Logothetis CJ, Chung LWK: Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J Urol 1993;149:1209-1213.
-
(1993)
J Urol
, vol.149
, pp. 1209-1213
-
-
Hoosein, N.M.1
Logothetis, C.J.2
Chung, L.W.K.3
-
14
-
-
0030787791
-
Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins
-
Aprikian AG, Tremblay L, Han K, Chevalier S: Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int J Cancer 1997;72:498-504.
-
(1997)
Int J Cancer
, vol.72
, pp. 498-504
-
-
Aprikian, A.G.1
Tremblay, L.2
Han, K.3
Chevalier, S.4
-
15
-
-
0026752724
-
Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160
-
Milovanovic SR, Radulovic S, Groot K, Schally AV: Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160. Prostate 1992;20:269-280.
-
(1992)
Prostate
, vol.20
, pp. 269-280
-
-
Milovanovic, S.R.1
Radulovic, S.2
Groot, K.3
Schally, A.V.4
-
16
-
-
0030751523
-
Luteinizing hormone-releasing hormone antagonist cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
-
Jungwirth A, Galvan G, Pinski J, Halmos G, Szepeshazi K, Cai RZ, Groot K, Schally AV: Luteinizing hormone-releasing hormone antagonist cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate 1997;32:164-172.
-
(1997)
Prostate
, vol.32
, pp. 164-172
-
-
Jungwirth, A.1
Galvan, G.2
Pinski, J.3
Halmos, G.4
Szepeshazi, K.5
Cai, R.Z.6
Groot, K.7
Schally, A.V.8
-
17
-
-
0002556848
-
Pulmonary endocrine cells in the developing human lung and during neonatal adaptation
-
Becker KL, Gazdar AF (eds) Philadelphia: WB Saunders
-
Cutz E, Gillan JE, Track NS: Pulmonary endocrine cells in the developing human lung and during neonatal adaptation. In Becker KL, Gazdar AF (eds): "Endocrine Lung in Health and Disease." Philadelphia: WB Saunders, 1984, pp 210-231.
-
(1984)
Endocrine Lung in Health and Disease
, pp. 210-231
-
-
Cutz, E.1
Gillan, J.E.2
Track, N.S.3
-
18
-
-
0027291922
-
The neuroendocrine cell population of the human prostate gland
-
Chen RJ, Glezerson G, Taylor LF, Grundle HAJ, Naude JH: The neuroendocrine cell population of the human prostate gland. J Urol 1993;150:365-368.
-
(1993)
J Urol
, vol.150
, pp. 365-368
-
-
Chen, R.J.1
Glezerson, G.2
Taylor, L.F.3
Grundle, H.A.J.4
Naude, J.H.5
-
19
-
-
0027972462
-
Multidirectional differentiation in the normal, hyperplastic and neoplastic human prostate: Simultaneous demonstration of cell-specific epithelial markers
-
Bonkoff H, Stein V, Remberger K: Multidirectional differentiation in the normal, hyperplastic and neoplastic human prostate: Simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 1994;25:42-46.
-
(1994)
Hum Pathol
, vol.25
, pp. 42-46
-
-
Bonkoff, H.1
Stein, V.2
Remberger, K.3
-
20
-
-
0023147441
-
Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells
-
Tutton PJM, Barkla DH: Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells. Anticancer Res 1987;7:1-12.
-
(1987)
Anticancer Res
, vol.7
, pp. 1-12
-
-
Tutton, P.J.M.1
Barkla, D.H.2
-
22
-
-
0025939537
-
Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate
-
Bonkoff H, Wernert N, Dhom G, Remberger K: Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate 1991;19:91-98.
-
(1991)
Prostate
, vol.19
, pp. 91-98
-
-
Bonkoff, H.1
Wernert, N.2
Dhom, G.3
Remberger, K.4
-
23
-
-
0025901008
-
Neuro-endocrine cells - A new prognostic parameter in prostate cancer
-
Cohen RJ, Glezerson G, Haffejee Z: Neuro-endocrine cells - A new prognostic parameter in prostate cancer. Br J Urol 1991;68:258-262.
-
(1991)
Br J Urol
, vol.68
, pp. 258-262
-
-
Cohen, R.J.1
Glezerson, G.2
Haffejee, Z.3
-
24
-
-
0030947224
-
The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy
-
Krijnen JLM, Bogdanowicz JFAT, Seldenrijk CE, Mulder PGH, Van Der Kwast TH: The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy. J Urol 1997;158:171-174.
-
(1997)
J Urol
, vol.158
, pp. 171-174
-
-
Krijnen, J.L.M.1
Bogdanowicz, J.F.A.T.2
Seldenrijk, C.E.3
Mulder, P.G.H.4
Van Der Kwast, T.H.5
-
25
-
-
0030015190
-
Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression following radical prostatectomy
-
Weinstein MH, Partin AW, Veltri RW, Epstein JI: Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression following radical prostatectomy. Hum Pathol 1996;27:683-687.
-
(1996)
Hum Pathol
, vol.27
, pp. 683-687
-
-
Weinstein, M.H.1
Partin, A.W.2
Veltri, R.W.3
Epstein, J.I.4
-
26
-
-
0023191097
-
Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases
-
Tetu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ, Ordonez NG: Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 1987;59:1803-1809.
-
(1987)
Cancer
, vol.59
, pp. 1803-1809
-
-
Tetu, B.1
Ro, J.Y.2
Ayala, A.G.3
Johnson, D.E.4
Ordonez Ng, L.C.J.5
-
27
-
-
0028128330
-
Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression
-
Cohen MK, Arber DA, Coffield KS, Keegan GT, McClintock J, Speights VO Jr: Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression. Cancer 1994;74:1899-1903.
-
(1994)
Cancer
, vol.74
, pp. 1899-1903
-
-
Cohen, M.K.1
Arber, D.A.2
Coffield, K.S.3
Keegan, G.T.4
McClintock, J.5
Speights Jr., V.O.6
-
28
-
-
0029113009
-
The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy
-
Noordzij MA, Van Der Kwast TH, Van Steenbrugge GJ, Hop WJ, Schroeder FH: The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy. Int J Cancer 1995;62:252-258.
-
(1995)
Int J Cancer
, vol.62
, pp. 252-258
-
-
Noordzij, M.A.1
Van Der Kwast, T.H.2
Van Steenbrugge, G.J.3
Hop, W.J.4
Schroeder, F.H.5
-
29
-
-
0022490255
-
Prostatic adenocarcinoma evolving into carcinoid: Selective effect of hormonal treatment
-
Stratton M, Evans DJ, Lambert IA: Prostatic adenocarcinoma evolving into carcinoid: Selective effect of hormonal treatment. J Clin Pathol 1986;39:750-756.
-
(1986)
J Clin Pathol
, vol.39
, pp. 750-756
-
-
Stratton, M.1
Evans, D.J.2
Lambert, I.A.3
|